Increased Immunogenicity of Tumor-Associated Antigen, Mucin 1, Engineered to Express -Gal Epitopes: A Novel Approach to Immunotherapy in Pancreatic Cancer
Increased Immunogenicity of Tumor-Associated Antigen, Mucin 1, Engineered to Express -Gal Epitopes: A Novel Approach to Immunotherapy in Pancreatic Cancer
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation